Latest News
November 27, 2017

ESSA Pharma Announces New Listing on the TSX Venture Exchange Concurrent with Voluntary Delisting from the TSX

September 11, 2017

ESSA PHARMA ANNOUNCES RESULTS FROM THE PHASE 1 CLINICAL TRIAL OF EPI-506 FOR TREATMENT OF mCRPC AND UPDATES CLINICAL AND STRATEGIC PLANS

September 07, 2017

ESSA Pharma Announces Abstract Presentation on EPI-506 at the European Society for Medical Oncology 2017 Congress

search-icon minus plus blue-dwn-arrow blue-right-arrow white-right-arrow white-right-arrows seffron-dwn-arrow seffron-up-arrow play-btn gray-left-arrow gray-right-arrow
error: Right click disabled